KD Logo

Ironwood Pharmaceuticals Inc [IRWD] Shares Fall -1.93 % on Wednesday

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ironwood Pharmaceuticals Inc shares valued at $143,198 were sold by McHugh Julie on Jun 10 ’24. At $6.29 per share, McHugh Julie sold 22,766 shares. The insider’s holdings dropped to 139,528 shares worth approximately $0.85 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Also, Moukheibir Catherine sold 35,574 shares, netting a total of over 235,144 in proceeds. Following the sale of shares at $6.61 each, the insider now holds 48,633 shares.

Before that, Moukheibir Catherine had sold 44,426 shares from its account. In a trade valued at $282,549, the Director traded Ironwood Pharmaceuticals Inc shares for $6.36 each. Upon closing the transaction, the insider’s holdings decreased to 44,426 shares, worth approximately $0.51 million.

As published in their initiating research note from Craig Hallum on January 17, 2024, Ironwood Pharmaceuticals Inc [IRWD] has been a Buy and the price target has been revised to $21. Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid December. As of November 09, 2023, Jefferies has initiated its “Buy” rating for IRWD. Earlier on September 28, 2023, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for IRWD stock.

Analyzing IRWD Stock Performance

During the last five days, there has been a drop of approximately -1.29%. Over the course of the year, Ironwood Pharmaceuticals Inc shares have dropped approximately -46.68%. Shares of the company reached a 52-week high of $15.70 on 02/14/24 and a 52-week low of $5.47 on 06/20/24. A 50-day SMA is recorded $6.73, while a 200-day SMA reached $9.61. Nevertheless, trading volume fell to 0.81 million shares from 1.16 million shares the previous day.

Support And Resistance Levels for Ironwood Pharmaceuticals Inc (IRWD)

According to the 24-hour chart, there is a support level at 6.03, which, if violated, would cause prices to drop to 5.96. In the upper region, resistance lies at 6.22. The next price resistance is at 6.34. RSI (Relative Strength Index) is 44.87 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.20, which suggests the price will decrease in the coming days. Percent R is at 47.54%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular